Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising AFFIRM‐AHF

European Journal of Heart Failure ◽

10.1002/ejhf.2270 ◽

2021 ◽

Author(s):

Phil McEwan ◽

Piotr Ponikowski ◽

Jason A. Davis ◽

Giuseppe Rosano ◽

Andrew J.S. Coats ◽

...

Keyword(s):

Heart Failure ◽

Cost Effectiveness ◽

Iron Deficiency ◽

Cost Effectiveness Analysis ◽

Ferric Carboxymaltose ◽

Effectiveness Analysis

Download Full-text

A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain

Revista Española de Cardiología (English Edition) ◽

10.1016/j.rec.2014.10.010 ◽

2015 ◽

Vol 68 (10) ◽

pp. 846-851 ◽

Cited By ~ 1

Author(s):

Josep Comín-Colet ◽

Darío Rubio-Rodríguez ◽

Carlos Rubio-Terrés ◽

Cristina Enjuanes-Grau ◽

Florian S. Gutzwiller ◽

...

Keyword(s):

Heart Failure ◽

Cost Effectiveness ◽

Chronic Heart Failure ◽

Iron Deficiency ◽

Cost Effectiveness Analysis ◽

Ferric Carboxymaltose ◽

Effectiveness Analysis

Download Full-text

PSY14 A PATIENT-LEVEL COST-EFFECTIVENESS ANALYSIS OF IRON ISOMALTOSIDE VERSUS FERRIC CARBOXYMALTOSE FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN THE UNITED KINGDOM

Value in Health ◽

10.1016/j.jval.2020.04.1441 ◽

2020 ◽

Vol 23 ◽

pp. S373 ◽

Cited By ~ 1

Author(s):

R. Pollock ◽

G. Muduma

Keyword(s):

United Kingdom ◽

Cost Effectiveness ◽

Iron Deficiency ◽

Iron Deficiency Anemia ◽

Cost Effectiveness Analysis ◽

Deficiency Anemia ◽

Ferric Carboxymaltose ◽

Patient Level ◽

The United Kingdom ◽

Effectiveness Analysis

Download Full-text

A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom

Journal of Medical Economics ◽

10.1080/13696998.2020.1745535 ◽

2020 ◽

Vol 23 (7) ◽

pp. 751-759 ◽

Cited By ~ 1

Author(s):

Richard F. Pollock ◽

Gorden Muduma

Keyword(s):

United Kingdom ◽

Cost Effectiveness ◽

Iron Deficiency ◽

Iron Deficiency Anemia ◽

Cost Effectiveness Analysis ◽

Deficiency Anemia ◽

Ferric Carboxymaltose ◽

Patient Level ◽

The United Kingdom ◽

Effectiveness Analysis

Download Full-text

PSY98 - COST-EFFECTIVENESS ANALYSIS OF FERRIC MALTOL VERSUS FERRIC CARBOXYMALTOSE FOR THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN IBD PATIENTS IN SWEDEN AND FINLAND

Value in Health ◽

10.1016/j.jval.2018.09.2673 ◽

2018 ◽

Vol 21 ◽

pp. S452-S453

Author(s):

J. Hjelmgren ◽

O. Ericson ◽

P. Niska ◽

P. Kukkonen ◽

G. Birgegård

Keyword(s):

Cost Effectiveness ◽

Iron Deficiency ◽

Iron Deficiency Anaemia ◽

Cost Effectiveness Analysis ◽

Ferric Carboxymaltose ◽

Deficiency Anaemia ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden

Journal of Medical Economics ◽

10.3111/13696998.2015.1029491 ◽

2015 ◽

Vol 18 (7) ◽

pp. 492-501 ◽

Cited By ~ 10

Author(s):

Thomas Hofmarcher ◽

Sixten Borg

Keyword(s):

Heart Failure ◽

Cost Effectiveness ◽

Chronic Heart Failure ◽

Cost Effectiveness Analysis ◽

Ferric Carboxymaltose ◽

Effectiveness Analysis ◽

Iron Deficient

Download Full-text

PSY13 Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland

Value in Health ◽

10.1016/j.jval.2020.08.2021 ◽

2020 ◽

Vol 23 ◽

pp. S744

Author(s):

A. Aksan ◽

A. Schöpfer ◽

P. Juillerat ◽

S. Vavricka ◽

M. Bettencourt ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Cost Effectiveness ◽

Iron Deficiency ◽

Bowel Disease ◽

Iron Deficiency Anaemia ◽

Cost Effectiveness Analysis ◽

Deficiency Anaemia ◽

Effectiveness Analysis ◽

Inflammatory Bowel

Download Full-text

Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1002/phar.2108 ◽

2018 ◽

Vol 38 (5) ◽

pp. 520-530 ◽

Cited By ~ 7

Author(s):

Patrick M. Zueger ◽

Varun M. Kumar ◽

Rachel L. Harrington ◽

Gianna C. Rigoni ◽

Alicia Atwood ◽

...

Keyword(s):

United States ◽

Heart Failure ◽

Cost Effectiveness ◽

Ejection Fraction ◽

The United States ◽

Cost Effectiveness Analysis ◽

Reduced Ejection Fraction ◽

Effectiveness Analysis

Download Full-text

PMD10 COST EFFECTIVENESS ANALYSIS OF CARDIAC RESYNCHRONIZATION THERAPY FOR HEART FAILURE FROM A PUBLIC THIRD-PARTY PAYER PERSPECTIVE IN CHILE

Value in Health ◽

10.1016/j.jval.2019.04.1008 ◽

2019 ◽

Vol 22 ◽

pp. S217-S218

Author(s):

R. Bitran ◽

M. Russo ◽

D. May ◽

J. Valencia

Keyword(s):

Heart Failure ◽

Cost Effectiveness ◽

Cardiac Resynchronization Therapy ◽

Cost Effectiveness Analysis ◽

Third Party ◽

Cardiac Resynchronization ◽

Resynchronization Therapy ◽

Party Payer ◽

Effectiveness Analysis ◽

Payer Perspective

Download Full-text

The Cost-Effectiveness Analysis of Philips Motiva Telehealth System: A Comparison Between Home Telemonitoring, Nurse Telephone Support And Usual Care In Chronic Heart Failure

Value in Health ◽

10.1016/j.jval.2015.09.681 ◽

2015 ◽

Vol 18 (7) ◽

pp. A358 ◽

Cited By ~ 2

Author(s):

AS Grustam ◽

JL Severens ◽

D de Massari ◽

R Koymans ◽

H Vrijhoef

Keyword(s):

Heart Failure ◽

Cost Effectiveness ◽

Chronic Heart Failure ◽

Usual Care ◽

Cost Effectiveness Analysis ◽

Telephone Support ◽

System A ◽

Effectiveness Analysis ◽

Home Telemonitoring ◽

The Cost

Download Full-text

CV12 A COST-EFFECTIVENESS ANALYSIS OF ACE INHIBITOR TRANDOLAPRIL AS A PREVENTATIVE TREATMENT OF HEART-FAILURE PROGRESSION

Value in Health ◽

10.1016/s1098-3015(10)61617-8 ◽

2003 ◽

Vol 6 (6) ◽

pp. 631

Author(s):

H Lilliu ◽

C Le Pen ◽

K Lamiraud ◽

W Wittenberg

Keyword(s):

Heart Failure ◽

Cost Effectiveness ◽

Ace Inhibitor ◽

Cost Effectiveness Analysis ◽

Preventative Treatment ◽

Effectiveness Analysis ◽

Heart Failure Progression

Download Full-text